ARYL OR HETEROARYL DERIVATIVE

A compound indicated by formula (I) or a pharmacologically acceptable salt thereof is provided as a compound that can be a therapeutic or prophylactic drug for TRPC6-related diseases, such as nephrotic syndrome, membranous nephropathy, acute renal failure, septicemia, chronic renal failure, diabetic...

Full description

Saved in:
Bibliographic Details
Main Authors MINAMIZONO, Kunio, HOSODA, Shinnosuke, SUGIYAMA, Sakae, JOHNSON, Brett M, MARUYAMA, Akinobu, ZHAO, Wei, WHITE, Ryan D, KAWANA, Asahi, YOKOSAKA, Takuya, KANEKO, Toshiyuki, KATO, Kenta, TAKEUCHI, Susumu, CHAKKA, Nagasree, SASAKI, Kosuke, KOSHIMIZU, Masaki
Format Patent
LanguageEnglish
Published 01.06.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:A compound indicated by formula (I) or a pharmacologically acceptable salt thereof is provided as a compound that can be a therapeutic or prophylactic drug for TRPC6-related diseases, such as nephrotic syndrome, membranous nephropathy, acute renal failure, septicemia, chronic renal failure, diabetic nephropathy, pulmonary hypertension, acute lung injury, heart failure, malignant tumor, and muscular dystrophy. (In the formula, Ar1, Ar2, X1-X3, R1, R3, R7, R8, L1, and L2 are as defined in the specifications.)
Bibliography:Application Number: US202117919186